logo
The Trump administration wants to ‘kill the clipboard'

The Trump administration wants to ‘kill the clipboard'

Politico29-07-2025
WASHINGTON WATCH
Roughly 60 entities in the health care sector will pledge to making patient data more accessible and speeding its delivery among patients, clinicians and payers, according to an HHS employee granted anonymity to discuss the sensitive plans. The White House and the Centers for Medicare and Medicaid Services are expected to announce the commitments on Wednesday, Ruth reported last week.
The agency hopes the commitments will stoke companies to make it easier for patients to import their data into an app of their choice, where they can manage their day-to-day health and easily share their history with doctors.
Pledges, not rules: The Trump administration has sought such commitments to compel the industry to make changes without having to engage in a lengthy rulemaking or guidance process.
But the federal government has tried similar tactics in the past.
In 2016, the then-secretary of the Department of Health and Human Services, Sylvia Burwell, under President Barack Obama, announced at a health IT conference that dozens of health industry organizations would commit to easing the flow of health information to patients. Nearly 10 years later, those voluntary commitments haven't materialized into better data access.
Still, the Trump administration thinks it can appeal to the private sector more effectively.
A joint effort: In a video posted Friday, Amy Gleason, strategic adviser to HHS and CMS and the acting administrator of the Department of Government Efficiency, asked viewers to envision the ability to instantly share their medical history via a QR code or manage their medications with an app.
'The future of health care technology can't come only from the government,' said Gleason. 'The apps, services and tools that make this data useful in people's lives comes from you, the private sector.'
Even though evidence that public pledges are more effective than regulation is scarce, industry might welcome the approach.
'The risk of … incremental regulatory compliance stuff is that you wind up spending all of your time trying to check boxes,' said Joe Ganley, vice president of regulatory affairs at electronic health record company Athenahealth.
What to watch for on Wednesday: The White House announcement is largely being driven by CMS, but the event could have implications for the ONC.
Health providers, data networks and payers are committing to expanding their use of Fast Healthcare Interoperability Resources, an open standard for transmitting data, according to a partial draft of a document obtained by POLITICO.
The increased use of FHIR may portend a shift in ONC's regulatory scope.
In her announcement, Gleason called on the health industry to help the government 'kill the clipboard.'
'Kill the Clipboard' is the name of a 2025 white paper by Ryan Howells, a one-time contender to lead the ONC and a principal at health management association Leavitt Partners based in Washington. It proposed ONC oversee how health care entities use FHIR.
Could ONC shift how it regulates and will this come up at the event? We'll be watching.
More to watch for: The draft also mandates data networks — entities that facilitate data exchange — create record-locating services. Requiring such services could be a boon for the ONC-supported data network, the Trusted Exchange Framework and Common Agreement, also known as TEFCA. Requiring those services could enable doctors to quickly access their patients' complete medical histories across providers, eliminating time-consuming record requests to multiple clinics.
WELCOME TO FUTURE PULSE
This is where we explore the ideas and innovators shaping health care.
Exercise, diet and socializing are key to slowing cognitive decline as people age, according to a new study, CNN reports.
Share any thoughts, news, tips and feedback with Carmen Paun at cpaun@politico.com, Ruth Reader at rreader@politico.com or Erin Schumaker at eschumaker@politico.com.
Want to share a tip securely? Message us on Signal: CarmenP.82, RuthReader.02 or ErinSchumaker.01.
WORLD VIEW
Dr. Jean-Claude Mulunda is concerned that the halt of U.S. funding for contraceptives will lead to an increase in the number of unintended pregnancies and unsafe abortions in the Democratic Republic of the Congo, his home country.
Mulunda leads the country's chapter of IPAS, an international nonprofit that aims to expand access to legal abortion and contraception.
Women there 'see themselves becoming pregnant just because there's no [contraceptive] method available,' Mulunda told Future Pulse.
Why it matters: The DRC has depended almost entirely on foreign-funded family-planning commodities, such as birth control pills, intrauterine devices, long-acting injectable drugs and condoms.
But since the Trump administration cut foreign aid and dismantled the U.S. Agency for International Development, which funded contraceptives, many clinics across the vast African country have been left without any stock, Mulunda said.
He's also worried that more women will seek unlicensed contraceptives from unauthorized suppliers, which could lead to potentially dangerous consequences if the products are unsafe.
That could also lead women to lose trust in contraception, Mulunda worries.
Meanwhile: The U.S. government is set to destroy 'certain [abortion-inducing] birth control commodities from terminated Biden-era USAID contracts,' a State Department spokesperson told Future Pulse.
The spokesperson didn't specify the types of contraceptives covered but added that no HIV drugs or condoms would be destroyed.
The Mexico City Policy: The federal government can't provide the contraceptives, including those it considers to be non-abortion-inducing, to entities that don't abide by the U.S.'s Mexico City Policy, the spokesperson said.
The policy prohibits U.S. funding from going to so-called foreign non-governmental organizations, or NGOs, that provide or promote abortion with funding from non-U.S. sources. President Donald Trump reinstated the policy — which all Republican presidents since Ronald Reagan have done — upon his return to office in January.
Going to waste? The contraceptives, stored in Belgium and set to be destroyed in France, have prompted calls for interventions from those countries' governments.
A Belgian foreign ministry spokesperson told NPR on Monday that the country is exploring possible avenues to prevent the contraceptives from being destroyed.
And in France, four members of the left-wing green political coalition, the Ecologists, asked President Emmanuel Macron in a public letter to find a way to impede the contraceptives' destruction and supply the products to NGOs interested in bringing them to their intended beneficiaries in low-income countries.
'Mister President, our country cannot become an accomplice, even indirectly, to backward policies, and cannot tolerate that vital medical resources be destroyed when they could save lives, prevent unwanted pregnancies and contribute to women's autonomy,' the lawmakers wrote.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Planned Parenthood shuts down in Louisiana over "political warfare"
Planned Parenthood shuts down in Louisiana over "political warfare"

Axios

time2 hours ago

  • Axios

Planned Parenthood shuts down in Louisiana over "political warfare"

Planned Parenthood will close its two Louisiana clinics and shut down all services by Sept. 30, the organization announced Monday. Why it matters: The nonprofit sexual health provider has for 40 years provided low- and no-cost primary care, preventative screenings and tests, and treatment and counseling for sexually transmitted infections. The big picture: Planned Parenthood's national organization warned in July that, with its Medicaid funding on the chopping block in President Trump's Big Beautiful Bill, about 60% of its subsidiaries were likely to close. Trump's efforts to "defund Planned Parenthood" have hit a snag in the courts, but the Gulf Coast branch of the organization announced two weeks ago that it would shut down two of its Houston clinics and transfer its remaining four to Planned Parenthood of Greater Texas, Houston Public Media reports. The closure of the organization's remaining facilities — one in New Orleans and another in Baton Rouge — are "a direct result of relentless political assaults," according to a statement from Planned Parenthood Gulf Coast CEO Melaney Linton. What they're saying: "This is not a decision we wanted to make; it is one we were forced into by political warfare," Linton continued. "We are not the first Planned Parenthood affiliate to face this reality, and we will not be the last," she said. "Every health center closure, every patient who goes without care, every undetected cancer and untreated infection is on those lawmakers' hands." By the numbers: While the organization has become a conservative political target for the access it provides to abortion services, Planned Parenthood has long provided additional sexual health care. The organization, for example, provided more than 10,600 visits for nearly 18,000 patients in Louisiana last year, a spokeswoman tells Axios New Orleans. They accounted for nearly 30,000 STI tests, 655 ultrasounds and 1,795 cancer screenings and prevention services, which identified 76 diagnoses of precancerous conditions, according to the spokeswoman. The Louisiana clinics also provided more than 14,000 birth control visits, including nearly 4,200 vasectomies. Go deeper

Trump administration allows six more states to bar SNAP benefits for processed food
Trump administration allows six more states to bar SNAP benefits for processed food

The Hill

time2 hours ago

  • The Hill

Trump administration allows six more states to bar SNAP benefits for processed food

The Trump administration on Monday approved six additional states seeking to ban food stamp recipients from purchasing processed food. Colorado, Louisiana, Oklahoma, West Virginia, Texas and Florida received federal waivers to adjust Supplemental Nutrition Assistance Program (SNAP) guidelines outlawing the purchase of junk food with state funds in 2026. Colorado was the first blue state to adopt the measure. 'SNAP is a supplemental nutrition program meant to provide health food benefits to low-income families to supplement their grocery budget so they can afford the nutritious food essential to health and well-being,' Agriculture Secretary Brooke Rollins said Monday before signing the waivers. 'That is the stated purpose of the SNAP program, the law states it and President Trump's USDA plans to deliver on it,' she added. Rollins approved the effort in May after Nebraska received the first federal waiver to ban soda and energy drinks from food stamps purchases. Health and Human Services Secretary Robert F. Kennedy Jr. has lauded the measure as a part of his 'Make America Healthy Again' campaign. 'U.S. taxpayers should not be paying to feed kids foods, the poorest kids in our country, with foods that are going to give them diabetes. And then my agency ends up, through Medicaid and Medicare, paying for those injuries,' Kennedy said on Monday. 'We're going to put an end to that, and we're doing it step by step, state by state,' he added. Researchers have long argued that SNAP restrictions are unlikely to change eating patterns, and that it will be costly for the federal government to track 650,000 food and beverage products on the market and 20,000 new products introduced annually, according to economic policy researcher Diane Whitmore Schanzenbach's 2017 testimony before the House Committee on Agriculture. However, Trump administration officials have lauded the effort. 'I hope to see all 50 states join this bold commonsense approach. For too long, the root causes of our chronic disease epidemic have been addressed with lip service only,' said the U.S. Food and Drug Commissioner Marty Makary, according to NBC News.

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Fast Company

time2 hours ago

  • Fast Company

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Subscribe to the Daily newsletter. Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock. Fast Company reached out for more details on the timeline and will update this post if we hear back.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store